NCT00806520View on ClinicalTrials.gov

Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Type 2 Diabetes
Trial Locations (5)

27713

University of North Carolina Diabetes Care Center, Durham

55416

International Diabetes Center, Minneapolis

89148

Palm Medical Group, Las Vegas

99202

Rockwood Clinic, Spokane

02215

Joslin Diabetes Center, Boston

Sponsors
All Listed Sponsors
collaborator

Amylin Pharmaceuticals, LLC.

INDUSTRY

lead

HealthPartners Institute

OTHER